You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for New Drug Application (NDA): 076523

✉ Email this page to a colleague

« Back to Dashboard

NDA 076523 describes MEFLOQUINE HYDROCHLORIDE, which is a drug marketed by Barr, Hikma, Hikma Intl Pharms, Sandoz, and Us Army Walter Reed, and is included in five NDAs. It is available from four suppliers. Additional details are available on the MEFLOQUINE HYDROCHLORIDE profile page.

The generic ingredient in MEFLOQUINE HYDROCHLORIDE is mefloquine hydrochloride. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the mefloquine hydrochloride profile page.

Summary for 076523

Tradename:	MEFLOQUINE HYDROCHLORIDE
Applicant:	Hikma
Ingredient:	mefloquine hydrochloride
Patents:	0

Pharmacology for NDA: 076523

Medical Subject Heading (MeSH) Categories for 076523

Antimalarials

Suppliers and Packaging for NDA: 076523

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
MEFLOQUINE HYDROCHLORIDE	mefloquine hydrochloride	TABLET;ORAL	076523	ANDA	Hikma Pharmaceuticals USA Inc.	0054-0025	0054-0025-11	1 BOTTLE in 1 CARTON (0054-0025-11) / 25 TABLET in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	250MG
Approval Date:	Oct 1, 2004	TE:	AB	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.